Shire
Shire centralizes its R&D data with AVEVA PI System
Shire, now part of Takeda, a biopharmaceutical company focused on rare diseases and specialty conditions, had to deal with more than 300 data sources from heterogeneous, vendor-specific operating software. This fragmentation forced researchers to keep their information in individual spreadsheets, hindering scientific efficiency and collaboration. Deploying AVEVA PI System, complemented by AVEVA PI Server and AVEVA PI Vision, made it possible to build a single source of truth for R&D activities. Bioreactor conditions are more visible and teams access a consolidated view of their experiments without multiplying manual handling. The benefits are measurable: between 2013 and 2015, the number of research programs grew by 50% with the same headcount. Shire is thus moving closer to therapies that can help patients around the world, while preserving its human and scientific resources.
Testimonials
FAQ
How does AVEVA PI System create a single source of truth in pharmaceutical R&D?
At Shire (now part of Takeda), AVEVA PI System consolidates more than 300 data sources from heterogeneous, vendor-specific operating software. Combined with AVEVA PI Server for industrial historization and AVEVA PI Vision for visualization, it gives researchers a consolidated, reliable view. This single source of truth eliminates individual spreadsheets and forms the foundation of collaborative, reproducible R&D in the life sciences.
How can research programs be increased by 50% without hiring more staff?
Between 2013 and 2015, Shire increased the number of research programs by 50% with the same headcount thanks to AVEVA PI System. Centralizing data, eliminating manual handling and gaining greater visibility into bioreactors freed up scientific time. This higher productivity illustrates how an industrial data management platform transforms innovation capacity without requiring a proportional investment in people.
What role does AVEVA PI Vision play in providing visibility into bioreactor conditions?
AVEVA PI Vision gives Shire researchers real-time dashboards on bioreactor conditions: temperature, pH, agitation, dissolved oxygen and metabolites. This visibility, shared between teams, speeds up process adjustments and the detection of deviations. It is a scientific management tool that transforms the quality of dialogue between R&D, quality and production departments in complex biopharmaceutical development.
Why eliminate individual spreadsheets in pharmaceutical R&D?
Individual spreadsheets, long a standard in R&D, raise issues of reliability, traceability and scientific reproducibility. AVEVA PI System replaces this fragmented approach with a centralized platform that ensures data integrity and security. For Shire, this transition strengthened scientific rigor, made collaboration between researchers easier and paved the way for applying advanced analytics tools such as artificial intelligence.
How does AVEVA PI Server support the development of treatments for rare diseases?
AVEVA PI Server provides the high-performance industrial historization infrastructure that underpins Shire/Takeda's entire data strategy. Reliable, fast access to data speeds up the experimentation loops that are essential for developing treatments for rare diseases. By reducing technical friction, AVEVA allows scientists to focus on their mission: bringing innovative treatments closer to patients around the world.